APAP-CYS Protein Adduct Concentrations in Patients With Liver-Directed Therapy Intended to Treat Hepatic Tumors
Condition(s):Acetaminophen ExposureLast Updated:September 2, 2021Withdrawn
Hide Studies Not Open or Pending
Condition(s):Acetaminophen ExposureLast Updated:September 2, 2021Withdrawn
Condition(s):AcetaminophenLast Updated:April 10, 2019Unknown status
Condition(s):Acetaminophen Metabolism; Acetaminophen Poisoning; Drug Metabolism by ExcipientsLast Updated:May 8, 2017Completed
Condition(s):Pain, Postoperative; Opioid UseLast Updated:August 10, 2021Completed
Condition(s):Multimodal Analgesic ApproachLast Updated:March 31, 2023Enrolling by invitation
Condition(s):Subarachnoid Hemorrhage; StrokeLast Updated:April 10, 2019Terminated
Condition(s):Osteoarthritis; Acetaminophen; Arthroplasty, Hip ReplacementLast Updated:March 9, 2021Completed
Condition(s):PainLast Updated:September 28, 2022Recruiting
Condition(s):Postoperative PainLast Updated:April 21, 2020Completed
Condition(s):Tonsillectomy; AdenoidectomyLast Updated:February 18, 2021Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.